Navigation Links
Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
Date:10/11/2007

(PHILADELPHIA) A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 which normally applies the brakes on a cancer-causing gene is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.

Scientists led by Jonathan Brody, Ph.D., assistant professor of Surgery, Charles Yeo, M.D., Samuel D. Gross Professor and chair of Surgery and Agnieszka Witkiewicz, M.D., assistant professor of Pathology, Anatomy and Cell Biology, all of Jefferson Medical College of Thomas Jefferson University, have shown in experimental models that without the protein, mutations in the cancer-causing gene K-ras can take over, turning cells cancerous. Adding pp32 to pancreatic cancer cells that have K-ras mutations and lack the protein can slow the growth of these fast-growing cells, leading the scientists to speculate that losing pp32 might be a critical event in determining how aggressively a pancreatic cancer behaves. They report their initial findings online in the journal Modern Pathology.

According to Dr. Brody, previous laboratory and animal studies have shown that pp32 inhibits K-ras-activating gene mutations found in more than 90 percent of all pancreatic cancers and in some early pre-cancerous lesions as well. But in a subset of fast-moving, poorly differentiated pancreatic cancers, the researchers found that pp32 is either reduced or lost, Dr. Brody says. Losing the protein in pre-cancerous lesions could be a marker for an aggressive form of pancreatic cancer.

Its rare to find laboratory studies that parallel what we see in actual pancreatic tumors, Dr. Brody says. Connecting a protein that can inhibit a critical mutation found in almost every pancreatic cancer to the pathology is powerful information. These types of studies can help us understand more about the early development of pancreatic cancer on a molecular level.

If we are able to learn more about this molecule, this may be a potential target that we could turn on in aggressive types of pancreatic cancers, he notes. In theory, if we could find a way to upregulate this molecule in these pancreatic cancers, we may be able to arrest these fast-growing cancer cells as we did in experiments in this study. As we understand its molecular interactions, we could also somehow find the things that regulate it and extend our molecular understanding of this devastating disease.

Pancreatic cancer, the fifth-leading cause of cancer death in this country, takes some 30,000 lives a year. The disease is difficult to treat, particularly because it is frequently detected after it has spread to other areas on the body. Only 4 percent of all individuals with pancreatic cancer live for five years after diagnosis, and approximately 25 percent of those diagnosed with pancreatic cancer who undergo successful surgical removal of their disease live at least that long. But recent figures give new hope: of those who live for five years after surgical resection, some 55 percent will be alive at least another five years.


'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Jefferson Physicians Report on Potentially Fatal Complication of Heart Attack
2. Jefferson Researchers Want to Learn If Heart Defect at Heart of Some Migraines
3. Nobel Prize for Medicine shared by Three scientists
4. Scientists plan human cloning clinic in the United States
5. Scientists crack mechanism of Leptin-Obesity Hormone
6. Scientists use plant hormones to fight cancer
7. American scientists alter gene makeup of babies
8. Expose on eating disorders!! Scientists trace “brain’s eating control center pathway”
9. Scientists found ancient Human Germ Killer
10. Scientists locate key hormone involved in appetite control
11. Scientists open the book of life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... ... charity program created to support and assist the people of their local community. ... with nonprofit organizations and community leaders. Their desire is to bring awareness to ...
(Date:5/6/2016)... Rafael, CA (PRWEB) , ... May 06, 2016 , ... ... an overnight youth rugby camp held at Oregon State University this summer. Employing world-class ... to benefit athletes of all skill levels with training on key fundamentals, match play, ...
(Date:5/6/2016)... PA (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular ... survey results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, ...
(Date:5/6/2016)... ... ... From the Speaker Podium to the Exhibit Floor at Booth#514, Worldwide Leading ... Customers Engagement at SpeechTek 2016 Event, taking place May 23-25 at the Omni Shoreham ... on “5 Customer Engagement Strategies to improve Customer Satisfaction in your Contact Center” ...
(Date:5/6/2016)... ... 06, 2016 , ... Multiple award winning plumbing company in San ... years. Maintaining core values of exceptional customer service, quality work at reasonable rates, and ... name in San Diego plumbing, and other services including heating & air conditioning and ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 5, 2016 Progra m m ... of Oxitec , s mosquito in ... by 96 %   Oxitec and ... to fight wild Aedes aegypti, the dangerous mosquito that spreads dengue, ... of Grand Cayman .  MRCU, a global leader in mosquito ...
(Date:5/5/2016)... , May 5, 2016 ... the addition of the  "Europe Thrombocythemia ... 2016"  report to their offering.  ... ) , ,The latest research Europe ... - 2016, provides comprehensive insights into ...
(Date:5/4/2016)... Diversified Holdings (NYSE: CODI ) ("CODI," "we," ... market businesses, announced today its consolidated operating results for ... First Quarter 2016 Highlights , Generated Cash Flow ... of $13.6 million for the first quarter of 2016; ... the first quarter of 2016; , Paid a ...
Breaking Medicine Technology: